Pharmacodynamic interaction of Momordica charantia with rosiglitazone in rats

Chemico-Biological Interactions

Volumn 177, Issue 3, 2009, Pages 247-253

  Nivitabishekam, Susan Nancy ^a   Asad, Mohammed ^a   Prasad, V Satya ^b  

^a KRUPANIDHI COLLEGE OF PHARMACY   (India)

^b MNR Medical College   (India)

Author keywords

Diabetes; Glucose tolerance; Momordica charantia; Rosiglitazone; Streptozotocin

Indexed keywords

GLUCOSE; MOMORDICA CHARANTIA EXTRACT; ROSIGLITAZONE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DRUG EFFECT; DRUG MEGADOSE; DRUG POTENTIATION; GLUCOSE BLOOD LEVEL; HISTOPATHOLOGY; HYPERGLYCEMIA; HYPOGLYCEMIA; LOW DRUG DOSE; MALE; MOMORDICA CHARANTIA; NONHUMAN; ORAL GLUCOSE TOLERANCE TEST; PANCREAS ISLET CELL; RAT; STREPTOZOCIN DIABETES;

ANIMALS; BLOOD GLUCOSE; DIABETES MELLITUS, EXPERIMENTAL; DRUG INTERACTIONS; GLUCOSE TOLERANCE TEST; MALE; MOMORDICA CHARANTIA; PLANT EXTRACTS; RATS; RATS, SPRAGUE-DAWLEY; STREPTOZOCIN; THIAZOLIDINEDIONES;

ANIMALIA; MOMORDICA CHARANTIA; RATTUS;

EID: 58349119767     PISSN: 00092797     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cbi.2008.09.034     Document Type: Article

References (39)

1. Chavez M.L., Jordan M.A., and Chavez P.I. Evidence-based drug-herbal interactions. Life Sci. 78 (2006) 2146-2157
2. Scheen A.J. Drug interactions of clinical importance with antihyperglycaemic agents: an update. Drug Safe. 28 (2005) 601-631
3. Zheng Z.X., Teng J.Y., Liu J.Y., et al. The hypoglycaemic effects of crude polysaccharides extract from Momordica charantia in mice. Wei Sheng Yan Jiu 34 (2005) 361-363
4. Sathishsekar D., and Subramanian S. Beneficial effects of Momordica charantia seeds in the treatment of STZ-induced diabetes in experimental rats. Biol. Pharm. Bull. 28 (2005) 978-983
5. Tongia A., Tongia S.K., and Dave M. Phytochemical determination and extraction of Momordica charantia fruit and its hypoglycemic potentiation of oral hypoglycemic drugs in diabetes mellitus (NIDDM). Indian J. Physiol. Pharmacol. 48 (2004) 241-244
6. Sarkar S., Pranava M., and Marita R. Demonstration of the hypoglycemic action of Momordica charantia in a validated animal model of diabetes. Pharmacol. Res. 33 (1996) 1-4
7. Gaikwada A.B., Viswanada B., and Ramarao P. PPAR-γ agonist partially restores hyperglycemia induced aggravation of vascular dysfunction to angiotensin II in thoracic aorta isolated from rats with insulin resistance. Pharmacol. Res. 55 (2007) 400-407
8. Shirwaikar A., Rajendran K., and Barik R. Effect of aqueous bark extract of Garuga pinnata Roxb. in streptozotocin-nicotinamide induced type-II diabetes mellitus. J. Ethnopharmacol. 107 (2006) 285-290
9. Kalpan L.A. Carbohydrates and metabolite. In: Kalpan L.A., and Pesce A.J. (Eds). Clinical Chemistry: Theory, Analysis and Co-relation (1984), C.V. Mosby, Toronto 1032-1040
10. Trinder P. Ann. Clin. Biochem. 6 (1969) 24
11. Arulmozhi D.K., Veeranjaneyulu A., and Bodhankar S.L. Neonatal streptozotocin-induced rat model of type II diabetes mellitus: a glance. Indian J. Pharmacol. 36 (2004) 217-221
12. Hu Z., Yang X., Ho P.C., et al. Herb-drug interactions: a literature review. Drugs 65 (2005) 1239-1282
13. Gohil K.J., and Patel J.A. Herb-drug interactions: a review and study based on assessment of clinical case reports in literature. Indian J. Pharmacol. 39 (2007) 129-139
14. B.N. Sastri, "Wealth of India-Raw Materials", Council of Scientific and Industrial Research, India 6 (1962) 376.
15. Shibib B.A., Khan L.A., and Rahman R. Hypoglycemic activity of Coccinia indica and Momordica charantia in diabetic rats: depression of the hepatic gluconeogenic enzymes glucose-6-phosphatase and fructose-1,6 bisphosphatase and elevation of both liver and red-cell shunt enzyme glucose-6-phosphate dehydrogenase. Biochem. J. 292 (1993) 267-270
16. Yibchok-Anun S., Adisakwattana S., Yao C.Y., et al. Slow acting protein extract from fruit pulp of Momordica charantia with insulin secretagogue and insulinomimetic activities. Biol. Pharm. Bull. 29 (2006) 1126-1131
17. Welihinda J., Arvidson G., Gylfe E., et al. The insulin releasing activity of the tropical plant Momordica charantia. Acta Biol. Med. Germ. 41 (1982) 1229-1240
18. Ahmed I., Adeghate E., Sharma A.K., et al. Effects of Momordica charantia fruit juice on islet morphology in the pancreas of the streptozotocin-diabetic rat. Diab. Res. Clin. Pract. 40 (1998) 145-151
19. Watt J.M., and Breyer-Brandwijk M.G. The Medicinal and Poisonous Plants of Southern and Eastern Africa. 2nd ed. (1962), E&S Livingstone, Edinburgh/London pp. 363-364
20. Marquis V.O., Adanlawo T.A., and Olaniyi A.A. The effect of foetidin from Momordica foetida on blood glucose level of albino rats. Planta Medica 31 (1977) 367-374
21. Iwu M.M. Catalog of major African medicinal plants. In: Iwu M.M. (Ed). Handbook of African Medicinal Plants (1993), CRC Press Inc., London 9-101
22. Hutchings A., Scott A.H., Lewis G., and Cunningham A.B. Zulu Medicinal Plants-An Inventory (1996), University of Natal Press, Pietermaritzburg pp. 303-305
23. Olaniyi A.A., and Marquis V.O. Phytochemical and preliminary pharmacological investigation of the alkaloid contained in Momordica foetida. Niger. J. Pharm. 6 (1975) 117-119
24. Olaniyi A.A. 1β-Hydroxyfriedel-6(7)-ene-3-one from Momordica foetida. Planta Medica 40 (1980) 303-305
25. Van Wyk B.-E., and Wink M. Medicinal Plants of the World. 1st ed. (2004), Briza Publ., Pretoria p. 417
26. http://www.healthscout.com/rxdetail/68/37/5/main.html, retrieved on 16-03-2008 at 2.15 pm IST.
27. Davis S.N. Insulin, oral hypoglycemic agents, and the pharmacology of the endocrine pancreas. In: Brunton L.L., Lazo J.S., and Parker K.L. (Eds). Goodman and Gilman's The Pharmacological Basis of Therapeutics. 11th ed. (2006), McGraw Hill, New York 1639
28. Szkudelski T. The mechanism of alloxan and streptozotocin action in β cells of the rat pancreas. Physiol. Res. 50 (2001) 536-546
29. Masiello P., Broca C., Gross R., Roye M., Manteghetti M., Hillaire-Buys D., Novelli M., and Ribes G. Experimental NIDDM: development of a new model in adult rats administered streptozotocin and nicotinamide. Diabetes 47 (1998) 224-229
30. Larsen M.O., Rolin B., Wilken M., Carr R.D., and Gotfredsen C.F. Measurements of insulin secretory capacity and glucose tolerance to predict pancreatic beta-cell mass in vivo in the nicotinamide/streptozotocin Göttingen minipig, a model of moderate insulin deficiency and diabetes. Diabetes 52 (2003) 118-123
31. Fierabracci V., De Tata V., Pocai A., Novelli M., Barberà A., and Masiello P. Oral tungstate treatment improves only transiently alteration of glucose metabolism in a new rat model of type 2 diabetes. Endocrine 19 (2002) 177-184
32. Ribel U., Larsen M.O., Rolin B., Carr R.D., Wilken M., Sturis J., Westergaard L., Deacon C.F., and Knudsen L.B. NN2211: a long-acting glucagon-like peptide-1 derivative with anti-diabetic effects in glucose-intolerant pigs. Eur. J. Pharmacol. 451 (2002) 217-225
33. Novelli M., Fabregat M.E., Fernandez-Alvarez J., Gomis R., and Masiello P. Metabolic and functional studies on isolated islets in a new rat model of type 2 diabetes. Mol. Cell. Endocrinol. 175 (2001) 57-66
34. Wang R.N., Bonwens L., and Kloppel G. Beta cell proliferation in normal and streptozotocin-treated newborn rats: site, dynamics and capacity. Diabetologia 37 (1994) 1088-1096
35. Baggio L.L., and Drucker D.J. Therapeutic approaches to preserve islet mass in type 2 diabetes. Ann. Rev. Med. 57 (2006) 265-281
36. Richardson H., Campbell S.C., Smith S.A., and Macfarlane W.M. Effects of rosiglitazone and metformin on pancreatic beta cell gene expression. Diabetologia 49 (2006) 685-696
37. C. Hellorstorm, A. Andersson, R. Gunnarsson, Regeneration of islets, in: International Symposium on the Immunological Aspects of Diabetes, Acta Endocrinol. (Suppl. 205) (1976) 145-158.
38. Weir G.C., Leahy J.L., and Weir S.B. Experimental reduction of β cell mass: implication for the pathogenesis of diabetes. Diab. Metab. Rev. 2 (1986) 125-161
39. Ovalle F., and Bell D.S. Effect of rosiglitazone versus insulin on the pancreatic beta-cell function of subjects with type 2 diabetes. Diab. Care 27 (2004) 2585-2589